NA-Semax-Amidate Side Effects: Safety Signals and Warnings
NA-Semax-Amidate safety concerns are compound-specific. The main listed side effects are Headache (extrapolated from Semax), Mild nasal irritation (intranasal), and Dizziness (rare). The main warning signals are No direct human clinical trials exist for NA-Semax-Amidate, Safety and efficacy data extrapolated from Semax research, and Dual modification may create unpredictable pharmacological differences.
Direct Answer
Evidence for NA-Semax-Amidate is too preliminary to support a research protocol with confidence. Like N-Acetyl Selank, this is a modified derivative of a Russian peptide with no independent clinical trials. The parent Semax has only Russian-sourced data. Cerebrolysin is a far better-evidenced starting point for cognitive enhancement research.
- Evidence grade
- Level D
- Research status
- Early Research
- Category
- Cognitive & Nootropic
- Evidence context
- Modified ACTH-analog cognitive peptide research (no independent clinical data)
Reported Side Effects
- Headache (extrapolated from Semax)
- Mild nasal irritation (intranasal)
- Dizziness (rare)
- Irritability at high doses
Warnings
- No direct human clinical trials exist for NA-Semax-Amidate
- Safety and efficacy data extrapolated from Semax research
- Dual modification may create unpredictable pharmacological differences
- Not approved for medical use in any jurisdiction
Known or Plausible Interactions
- Stimulants (potential additive cognitive effects)
- Melanocortin receptor agonists (overlapping pathways)
- N-Acetyl Selank (commonly combined by users for cognitive + anxiolytic stack)
Regulatory Context
Unregulated research peptide in most countries.
Evidence Snapshot
| Evidence grade | Level D |
|---|---|
| Research status | Early Research |
| Best supported outcomes | Cognitive Enhancement (extrapolated from Semax) (Level D), Enhanced Metabolic Stability (Level D), and Neuroprotection (extrapolated) (Level D) |
| Primary citation count | 3 |
| Last reviewed | 2026-08-27 |
Quick Answers
What are the side effects of NA-Semax-Amidate?
NA-Semax-Amidate safety concerns are compound-specific. The main listed side effects are Headache (extrapolated from Semax), Mild nasal irritation (intranasal), and Dizziness (rare). The main warning signals are No direct human clinical trials exist for NA-Semax-Amidate, Safety and efficacy data extrapolated from Semax research, and Dual modification may create unpredictable pharmacological differences.
What is the evidence level for NA-Semax-Amidate?
NA-Semax-Amidate is rated Level D. Its current research status is Early Research.
What is NA-Semax-Amidate best known for?
Modified ACTH-analog cognitive peptide research (no independent clinical data).
Where can I read the full NA-Semax-Amidate evidence review?
The full evidence review is available at https://examinepeptides.com/library/na-semax-amidate.
Related Guides
How to Cite This Page
ExaminePeptides. "NA-Semax-Amidate Side Effects: Safety Signals and Warnings." Last reviewed 2026-08-27. https://examinepeptides.com/answers/na-semax-amidate-side-effects-safety/
This static answer page is built for fast indexing and direct citation. It summarizes the matching full evidence review and links back to primary sources where the source database includes them.